Medicaid Expansion and Restriction Policies for Hepatitis C Treatment.

ABSTRACT:

Importance

Hepatitis C can be cured with direct-acting antivirals (DAAs), but Medicaid programs have implemented fibrosis, sobriety, and prescriber restrictions to control costs. Although restrictions are easing, understanding their association with hepatitis C treatment rates is crucial to inform policies that increase access to lifesaving treatment.

Objective

To estimate the association of jurisdictional (50 states and Washington, DC) DAA restrictions and Medicaid expansion with the number of Medicaid recipients with filled prescriptions for DAAs.

Design, setting, and participants

This cross-sectional study used publicly available Medicaid documents and claims data from January 1, 2014, to December 31, 2021, to compare the number of unique Medicaid recipients treate

SUBMITTER: Furukawa NW 

PROVIDER: S-EPMC11252896 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature